United States Breaking News

National Energy Services Reunited (NASDAQ:NESR) signed an agreement with Aramco for a lithium demonstration project in Saudi Arabia valued at approximately $200 million.

Anna Edwards, Guy Johnson, and Paul Dobson break down today's key themes for analysts and investors on "Bloomberg: The Opening Trade."

Applied Digital (NASDAQ:APLD) reported first-quarter revenue of $341.9 million, more than quadrupling from a year earlier and exceeding analysts’ average estimate of $133.8 million.

Bollywood makes more movies but doesn't have the global impact of Hollywood. JioStar Vice Chairman Uday Shankar tells Bloomberg's Haslinda Amin why it hasn't achieved world scale, and what needs to change.

Brent crude (ICE:BZ) rose just under 4% to $104.18 per barrel on Thursday as renewed tensions involving the United States and Iran increased concerns about global oil supplies.

SpaceX’s (NASDAQ:SPCX) Starlink said it remains ready to launch satellite internet service in India, but the government said the company must complete security assessments before it can seek spectrum.

Taiwan Semiconductor Manufacturing (NYSE:TSM) reported third-quarter 2026 revenue of NT$1.49 trillion, or about $46.7 billion, representing roughly 51% year-over-year growth and exceeding analyst expectations of NT$1.46 trillion.

Nataliia Lipikhina, head of EMEA equity strategy at JPMorgan Private Bank, discusses how artificial intelligence continues to underpin global equity markets, particularly the tech sector. "I think the market comes to realization that actually the AI story continues," she tells Bloomberg Television. "Demand is still really strong, and supply is still constrained," Lipikhina adds.

Biohaven (NYSE:BHVN) entered an exclusive regional licensing agreement with Ono Pharmaceutical covering its IgG degrader portfolio, with near-term payments of up to $100 million.

XPENG (NYSE:XPEV) completed the first production trial of its G9L SUV at Magna’s Graz, Austria facility, making it the fourth XPENG model to undergo production there.

LEIFRAS (NASDAQ:LFS) reported unaudited first-half fiscal 2026 revenue of JPY5,978.8 million for the six months ended June 30, up 8.9% from a year earlier.

argenx (NASDAQ:ARGX) said its Phase 2 study of FB102 in adults with celiac disease met its primary endpoint, showing a statistically significant improvement versus placebo at day 78 with a p-value of 0.0176.